Analysts: Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

2.67USD
1 Aug 2013
Price Change (% chg)

$0.08 (+3.09%)
Prev Close
$2.59
Open
$2.64
Day's High
$2.67
Day's Low
$2.54
Volume
28,380
Avg. Vol
88,908
52-wk High
$3.25
52-wk Low
$1.09

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.33 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 3 3 3 3
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.40 3.40 3.40 3.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 4 7.34 8.00 6.68 4.48
Quarter Ending Dec-13 4 8.35 9.00 7.22 5.26
Year Ending Dec-13 5 27.23 29.00 26.25 23.51
Year Ending Dec-14 5 34.84 40.94 29.50 25.17
Earnings (per share)
Quarter Ending Sep-13 5 -0.33 -0.25 -0.38 -0.42
Quarter Ending Dec-13 5 -0.33 -0.28 -0.38 -0.42
Year Ending Dec-13 5 -1.37 -1.22 -1.50 -1.65
Year Ending Dec-14 5 -1.18 -0.77 -1.48 -1.49

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 5.29 5.58 0.29 5.42
Quarter Ending Dec-12 4.38 5.88 1.50 34.12
Quarter Ending Sep-12 3.12 2.78 0.34 10.98
Quarter Ending Jun-12 6.89 7.29 0.40 5.82
Quarter Ending Mar-12 7.11 10.04 2.92 41.11
Earnings (per share)
Quarter Ending Mar-13 -0.38 -0.37 0.01 -1.60
Quarter Ending Dec-12 -0.37 -0.39 0.02 -4.28
Quarter Ending Sep-12 -0.43 -0.41 0.02 -5.09
Quarter Ending Jun-12 -0.46 -0.40 0.06 -13.79
Quarter Ending Mar-12 -0.47 -0.50 0.03 -7.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 7.34 7.34 7.34 7.34 4.48
Quarter Ending Dec-13 8.35 8.35 8.35 8.35 5.26
Year Ending Dec-13 27.23 27.23 27.23 27.23 23.51
Year Ending Dec-14 34.84 34.84 34.84 34.84 25.17
Earnings (per share)
Quarter Ending Sep-13 -0.33 -0.33 -0.33 -0.33 -0.42
Quarter Ending Dec-13 -0.33 -0.33 -0.33 -0.33 -0.42
Quarter Ending Dec-13 -1.37 -1.37 -1.37 -1.37 -1.65
Quarter Ending Dec-14 -1.18 -1.18 -1.18 -1.18 -1.49

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 1 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 1 1
Year Ending Dec-14 0 0 1 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Wright Reports
$460.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks